| FAGRON N.V. PORT. |
| Belgien |
| Gesundheit |
| BE0003874915 / A0M103 |
| 4A5 (Frankfurt) |
| FRA:4A5, ETR:4A5, 4A5:GR |
| - |
| https://fagron.com/ |
|
Fagron NV is a publicly traded multinational company governed by Belgian law, specializing in pharmaceutical compounding to enable personalized medicine for hospitals, pharmacies, clinics, and patients worldwide. Headquartered in Rotterdam, Netherlan..
>Volltext.. |
| 1571.25 Mio. EUR |
| 1856.66 Mio. EUR |
| 966.94 Mio. EUR |
| 193.39 Mio. EUR |
| 92.43 Mio. EUR |
| 1.26 EUR |
| 475.49 Mio. EUR |
| 187.77 Mio. EUR |
| 130.27 Mio. EUR |
| 0.84 |
| 9.2% |
| 12.99% |
| 0.35 EUR |
| 1.16% |
| 1.31% |
| 19.05.25 - 0.35€ 21.05.24 - 0.3€ >weitere anzeigen... |
| - |
| FAGRON |
| 01.04.26 |
|